Kelly Abernethy

Kelly Abernethy is an experienced professional in the pharmaceutical industry, currently serving as the Director of Execution at Exela Pharma Sciences LLC since August 2023. Prior to this role, Kelly was a Product Development Scientist at SynergyLabs from July 2022 to July 2023. Kelly's extensive tenure at Exela Pharma Sciences LLC spanned from September 2009 to June 2022, where multiple positions were held, including Director of Research and Development, Associate Director of Research and Development, Research and Development Senior Manager, Research and Development Manager, and Staff Scientist. Educationally, Kelly holds a Master's degree and a Bachelor of Science degree in Chemistry from Western Carolina University, obtained between 2003 and 2008.